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Abstract—This study quantified selection by analyzing the sur-
vival rate of the participants and nonparticipants in a 4-year pro-
spective, multicenter cohort study. In addition, the differences 
between these groups were analyzed. Surgeons of six hospitals 
in the northern Netherlands referred, in total, 225 patients to the 
study. Of these patients, 60% (n = 134) participated in the pro-
spective study by filling in questionnaires; the others (nonpar-
ticipants) were followed over time through their records. No 
significant differences were found in sex and level of amputa-
tion between participants and nonparticipants; however, of the 
two groups, nonparticipants were significantly older. Reason for 
amputation was peripheral vascular disease (PVD) for 67% (n = 
90) of the participants and 82% (n = 75) of the nonparticipants. 
The mean survival time of the participants and nonparticipants 
was 36.1 and 29.6 months, respectively. Within PVD, the mean 
survival time of participants and nonparticipants was 34.4 and 
27.6 months, respectively. To summarize, our article gives an 
overview of the survival rates in a prospective study on patients 
scheduled for a limb amputation. Our study sample was biased 
by selection and death. Participants were generally healthier 
than nonparticipants.
Key words: bias, cancer, complex regional pain syndrome 
type I, CRPS I, Kaplan-Meier curves, limb amputation, multi-
center study, peripheral vascular disease, prospective study, 
rehabilitation, survival, trauma.
INTRODUCTION
From historical cohort studies the patient survival 
rate after a lower-limb amputation because of vascular 
problems is clearly moderate to low over time [1–12]. 
However, prospective studies on lower-limb amputees 
seldom report their survival rates, inclusion and exclu-
sion criteria, and/or referral and dropout rates (death 
included) [13–20]. Thus, in these studies, little is known 
about bias through selective referral, number of dropouts, 
or mortality. The same is true for studies concerning pre-
dictors of functional outcome or quality of life after a 
lower-limb amputation [21–27].
In amputation research, selection bias in study sam-
ples has probably occurred but has seldom been quanti-
fied. A consequence of this selection is that amputees 
who managed to reach the prosthetic stage of the rehabil-
itation process were a small subset of those who have 
had an amputation. However, in research, one wants to 
Abbreviations: CRPS I = complex regional pain syndrome 
type I, PVD = peripheral vascular disease, UMCG = University 
Medical Center Groningen.
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tion. To be able to do so, researchers must use a random 
sample from the target population, which should have the 
same properties as the research population from which 
the research sample is drawn.
In 2003, a 4-year prospective multicenter cohort study 
on limb amputees was initiated at the University Medical 
Center Groningen (UMCG), Groningen, the Netherlands. 
During that prospective study, apparently, selection also 
occurred and a substantial number of patients referred did 
not fulfill inclusion criteria and, consequently, became 
nonparticipants. In the current study, we aimed to quantify 
selection by analyzing the survival rate of the participants 
and nonparticipants studied. In addition, the differences 
between these groups were analyzed.
METHODS
Patients
Patients scheduled for limb amputation were 
recruited for a prospective study in the northern Nether-
lands from November 2003 to May 2007. The survival 
data presented here were part of this prospective multi-
center cohort study on phantom pain, phantom sensa-
tions, and residual-limb pain after a limb amputation. To 
ensure sufficient inflow of patients, vascular surgeons in 
12 of the 13 hospitals in the northern Netherlands and 
surgeons of UMCG’s oncological, orthopedic, and hand 
surgery and traumatology departments were asked to par-
ticipate. Surgeons were invited to a meeting in which 
they were informed about the aims and logistics of the 
study. After the meeting, the surgeons received a written 
copy of the agreements made during the meeting. In 
addition, they were sent the inclusion and exclusion crite-
ria, procedures for referring patients to the primary inves-
tigator, and the period they could refer potential 
candidates (November 2003–May 2007). Surgeons also 
agreed that if they decided to exclude a patient, they 
would send the researcher the patient’s characteristics 
and surgical information.
During the study, we sent eight newsletters contain-
ing both the current state of affairs and a reminder to 
refer patients to all surgeons. In addition, we regularly 
telephoned the hospital wards in question. About halfway 
through the study, we presented information to the sur-
geons about the number of patients included and 
excluded by hospital.
Inclusion criteria for the prospective study were (1) a 
minimum age of 18 years, (2) an amputation level 
through the metacarpophalangeal or metatarsophalangeal 
joints or more proximal, (3) a first amputation of the 
limb, (4) the ability to fill in the first questionnaire before 
the amputation or not more than 5 days after the amputa-
tion, and (5) a sufficient command of spoken and written 
Dutch to fill in questionnaires. Patients were excluded if 
they were too ill to fill in the questionnaires or showed 
signs of clinical dementia to such an extent that they 
could not be expected to fill in the questionnaires 
(comorbidity).
Data Entry
We recorded patients’ characteristics and the reason 
for, the level of, and date of amputation. Lower-limb 
amputations were categorized as distal (transtibial, ankle, 
or foot), knee disarticulation, or proximal (pelvis, hip, or 
transfemoral). Upper-limb amputations were categorized 
as distal (transradial or wrist) or proximal (forequarter, 
shoulder, or transhumeral); no elbow disarticulations had 
been performed. If patients underwent a second amputa-
tion of the same limb during the study period, we used 
the date of the first amputation for statistical analyses. If 
a patient died during the follow-up, we noted the date of 
death. On 1 November 2007, we investigated the survival 
rate of all patients referred by analyzing their records 
kept by participating hospitals or by consulting the 
patients’ general practitioners.
Participants were patients who filled in question-
naires over time, and nonparticipants were followed over 
time through their records. Detailed outcomes of the pro-
spective study have been reported elsewhere [28].
Statistics
We analyzed descriptive statistics using SPSS ver-
sion 16.0 (Chicago, Illinois) for Windows. Differences 
between the participants and nonparticipants were ana-
lyzed with t-tests for independent samples and 2-tests, 
as appropriate. Kaplan-Meier survival curves were drawn 
for the participants and nonparticipants and log-rank tests 
were completed. Values of p  0.05 were considered sta-
tistically significant. Data are presented in tables, 
enabling detailed comparison with literature data, and in 
figures, providing an overview of events over time.
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Patients were referred from one university hospital 
and five general hospitals in the northern Netherlands. In 
total, the data of 225 patients referred were available. Of 
these patients, 134 (participants) were followed longitu-
dinally by means of questionnaires during a maximum of 
4 years and 91 (nonparticipants) were only followed over 
time through their records (16 patients refused to partici-
pate and 75 patients did not meet the inclusion criteria). 
Of those not meeting the inclusion criteria, 46 patients 
were too ill or had signs of a clinical dementia, 7 had a 
previous ipsilateral amputation, 19 exceeded the time 
interval by 5 days between amputation and the first ques-
tionnaire, 1 was younger than 18 years, and 2 patients did 
not speak or read Dutch (Figure 1).
The patients’ characteristics and the reason for and 
level of amputation are summarized in Table 1. No 
significant differences were found in sex (p = 0.50) and 
level of amputation (p = 0.50) between participants and 
nonparticipants. Nonparticipants were significantly older 
than participants (p = 0.04). More nonparticipants (82%) 
than participants (67%) had an amputation because of
peripheral vascular disease (PVD), whereas more partici-
pants had an amputation because of trauma or complex 
regional pain syndrome type I (CRPS I) or cancer (p = 
0.03) (Table 1). Within the group of patients who had an 
amputation because of PVD, no significant differences in 
age (mean ± standard deviation) between the nonpartici-
pants (71.0 ± 12.5 yr) and participants (67.2 ± 13.3 yr) 
were found (p = 0.06). Of those who survived amputa-
tion, no significant difference was found between the 
overall number of participants (73%) and nonparticipants 
(63%) (p = 0.10). However, the mean survival time of 
participants (36.1 months) was significantly longer than 
that of nonparticipants (29.6 months) (log-rank test p = 
0.03) (Figure 2).
Of the patients who had an amputation because of 
PVD (165) or cancer (27), 64 percent survived, while all 
patients who had an amputation because of trauma or 
CRPS I (33) survived (log-rank test p < 0.001) (Figure 3). 
Within the group of patients who had an amputation 
because of PVD, the mean survival time of participants 
(34.4 months) was generally longer than that of nonpartici-
pants (27.6 months) (log-rank test, p = 0.05).
All patients’ mean survival time after a proximal 
amputation was 30.0 months, after a knee disarticulation 
36.5 months, and after a distal amputation 34.9 months 
(log-rank test p = 0.25) (Figure 4). Detailed 4-year sur-
vival data of all amputees, categorized according to sex 
and reason for and level of amputation, are presented in 
Table 2.
Within the group of amputees, 6 percent (n = 14) had 
had an upper-limb amputation that was proximal in 
71 percent (n = 10) of the patients. The main reason for 
upper-limb amputation was a trauma or CRPS I (71%, n = 
10). One of the participants with an upper-limb amputa-
tion died from cancer 6.5 months after his amputation.
DISCUSSION
The results of the current study confirm a moderate 
survival rate of patients after a limb amputation. Overall, 
a larger percentage of the participants survived than 
nonparticipants.
As we have already stated, in research, one wants to 
generalize the study results to the target population. To be 
able to do so, researchers must use a random sample from 
the target population. Looking at the survival rates of the 
participants and nonparticipants found in the current 
study, we noted a clear bias in population: a healthier and 
somewhat younger population with less vascular amputa-
tions participated.
When the survival rates of the current study were 
compared with those of other prospective studies on 
amputation and phantom pain, we found that the prospec-
tive studies only reported survival of included patients, as 
a rule. The reported survival rate ranges from 59 to 
Figure 1.
Flow diagram of patients referred by hospitals.
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from 59 to 67 percent 12 months after amputation [15–
16,18–20]. Only one study provided a 2-year follow-up 
[14]: the survival rate was 59 percent. The numbers of 
amputees who participated in these prospective studies 
were relatively small (n = 21 to n = 60). The studies 
mainly included patients who had an amputation because 
of PVD—a group of amputees having a large chance of 
dying relatively soon after the amputation. Furthermore, 
the studies seldom provided the number of patients 
referred to the study, the number of patients excluded and 
the reasons for exclusion, and the dropout rate by death 
[13–17,20]. Consequently, the type of selection bias that 
Table 1.
Characteristics, reason for and level of amputation, and overall number of survivors during study for participants and nonparticipants with limb 
amputation.
Variable







Sex, % (n) 0.50
Female 37 (50) 42 (38)
Male 63 (84) 58 (53)
Age, mean ± SD 62.0 ± 16.7 66.8 ± 17.4 0.04
Amputation Reason, % (n) 0.03
PVD 67 (90) 82 (75)
Cancer 13 (18) 10 (9)
Trauma or CRPS I 19 (26) 8 (7)
Amputation Level, % (n) 0.50
Proximal Amputation 30 (40) 37 (34)
Knee Disarticulation 15 (20) 13 (12)
Distal Amputation 55 (74) 50 (45)
Overall Survival, % (n) 73 (98) 63 (57)  0.10
Note: Reasons for amputation were either PVD with and without diabetes mellitus, ulcer, infection (PVD), cancer, or trauma or CRPS I. Levels of amputation of 
lower limb were either proximal (pelvis, hip, or transfemoral) or knee disarticulation or distal (transtibial, ankle, or foot). Levels of amputation of upper limb were 
either proximal (forequarter, shoulder, or transhumeral) or distal (transradial or wrist).
CRPS I = complex regional pain syndrome type I, PVD = peripheral vascular disease, SD = standard deviation.
Figure 2.
Kaplan-Meier survival curves of all limb amputees (patients) (N = 
225), participants (n = 134), and nonparticipants (n = 91). Difference 
in survival between participants and nonparticipants was significant 
(p = 0.03).
Figure 3.
Kaplan-Meier survival curves of all limb amputees according to 
reason for amputation (peripheral vascular disease [PVD] [n = 165], 
cancer [n = 27], or trauma or CRPS I [n = 33]). Difference in survival 
between trauma patients and PVD and cancer patients was significant 
(p < 0.001).
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studies as in our study, they probably investigated 
a healthier and younger subset of amputees [13–17]. Only 
Nikolajsen et al. reported the number of patients sched-
uled for an amputation (n = 157), patients excluded (97/
157) and reasons for exclusion, and dropouts (death 
included) [18–19]. They also reported that participants 
were healthier than nonparticipants. Other authors 
reported the number of dropouts [17,20], the reason for 
excluding patients [13–17], or the number of patients 
excluded [17]. Consequently, survival data from our cur-
rent study cannot be adequately compared with data of 
those studies. However, from the data in studies by 
Nikolajsen et al. [18–19], one can deduce that at least 
44 percent of the excluded patients were in poorer general 
health than included patients. Other studies have not 
clearly reported how many patients were excluded for rea-
sons of poor general health.
Concerning predictors of functional outcome after a 
limb amputation, excluding severely disabled patients, a 
prospective study found a survival rate of 85 percent 
within the first year [23]. Primarily, patients who went to 
a nursing home died, probably because of poor general 
health. Perhaps this study’s survival rate was high com-
pared with that of other prospective studies because of its 
exclusion criteria (patients not understanding the test 
instructions and being severely disabled without any 
walking ability before the amputation for reasons not 
related to PVD) [23]. In cross-sectional studies concern-
ing functional outcome after a limb amputation, survival 
rates were not a concern because only survivors could be 
selected [21–22,24–27,29]. Additionally, explicit inclu-
sion or exclusion criteria for those studies were seldom 
specified, except that the patients had to have undergone 
a lower-limb amputation and referred for a limb fitting 
(these patients formed a kind of convenience sample).
In historical cohort studies, an estimation of the sur-
vival rates after amputation is obtained from historical 
data, usually from different sources (general databases, 
hospital records, and medical insurance and Central Per-
son Register databases). The total number of patients 
amputated is known, and the number of deaths is recorded 
as usual.
In certain historical cohort studies, the 1-year survival 
rates ranged from 49 to 73 percent [1–2,4,8,10,12,30] and 
the longer term (interval 5-year) survival rates were 
26 percent [1–2,12]. The number of patient records in 
these historical cohort studies was large (n = 174 to n = 
21,520) [1–2,4,6,8–11,30].
The limitation of the current study is that the number 
of referred patients scheduled for a lower-limb amputa-
tion was considerably smaller than expected. On the basis 
of earlier Dutch amputation studies [3,21], the population 
of the northern Netherlands (comprising the provinces of 
Table 2.
Survival rates in percentages of limb amputees on basis of Kaplan-
Meier analyses for all patients referred, according to sex and reason 
for and level of amputation.
Variable (n) 6 Mo 1 Yr 2 Yr 3 Yr 4 Yr
All Limb Amputees (225) 79 75 70 63 61
Participants (134) 85 80 73 68 68
Nonparticipants (91) 71 68 65 56 49
Sex
Male (137) 80 73 65 62 58
Female (88) 79 78 77 66 66
Reason for Amputation
PVD (165) 76 72 66 57 53
Cancer (27) 78 62 51 51 51
Trauma or CRPS I (33) 100 100 100 100 100
Level of Amputation
Proximal (74) 75 69 63 58 52
Knee Disarticulation (32) 81 81 77 72 72
Distal (119) 82 77 72 64 64
CRPS I = complex regional pain syndrome type I, PVD = peripheral vascular 
disease.
Figure 4.
Kaplan-Meier survival curves of all limb amputees according to level 
of amputation (proximal leg = pelvis, hip, or transfemoral and proxi-
mal arm = forequarter, shoulder, or transhumeral [n = 74]; knee disar-
ticulation [n = 32]; or distal leg = transtibial, ankle, or foot and distal 
arm = transradial or wrist [n = 119]). Difference in survival between 
different levels was not significant (p = 0.25).
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of participating hospitals, an estimated 150 to 170 new 
patients with a lower-limb amputation could be referred 
to the current study each year. Despite all efforts, only 
35 to 40 percent (n = 211, inclusion period 3 1/2 years) of 
the estimated population of lower-limb amputees in the 
northern Netherlands were referred, indicating a consid-
erable selection bias. Surgeons from only six hospitals 
referred patients. The reasons why surgeons did not par-
ticipate in the study, despite having previously indicated 
a willingness to participate and despite regular reminders, 
have remained unclear.
Selection bias has probably not occurred for upper-
limb amputees. Of the 225 patients referred, 14 patients 
were scheduled for or had undergone an upper-limb 
amputation (through wrist or more proximal), of whom 
10 patients had experienced a trauma or CRPS I. This 
result means an incidence of 0.2/100,000 in the northern 
Netherlands. Our rate corresponds with the incidence rate 
of traumatic upper-limb amputations in Sweden, Norway, 
and the United States, where rates of 0.1, 0.1, and 0.4/
100,000 inhabitants, respectively, have been reported 
[32–34]. In the northern Netherlands, patients with an 
upper-limb amputation are mainly treated at UMCG. We 
recommend that future research more clearly report 
inclusion and exclusion criteria and referral rates.
CONCLUSIONS
In this article, we have given survival rates in a pro-
spective study on patients scheduled for a limb amputa-
tion. Our study sample of patients is biased by selection 
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